Literature DB >> 20542397

Pneumopericardium with cardiac tamponade as a complication of cardiac pacemaker insertion one year after procedure.

Rory O'Neill1, Marc Silver, Fahim Khorfan.   

Abstract

BACKGROUND: Lead dislodgement has been shown to be the most common complication in the first 30 days after pacemaker insertion. Although it is rare, pneumopericardium with tamponade can also result.
OBJECTIVES: We present a case of an extremely rare delay from cardiac pacemaker insertion to lead migration with resulting pneumopericardium and cardiac tamponade. CASE REPORT: A 65-year-old woman with a past medical history significant for congestive heart failure, chronic obstructive pulmonary disease, and third-degree heart block, requiring pacemaker insertion 2 years prior with a revision 1 year prior, presented to the Emergency Department complaining of sudden-onset pleuritic chest pain. Her work-up revealed a pneumopericardium with atrial pacemaker lead migration into the right middle lobe of the lung. She suddenly developed hypotension and respiratory distress and required pericardiocentesis and, ultimately, surgical repair for a perforated right atrium.
CONCLUSION: Pacemaker migration can lead to pneumopericardium and tamponade, even up to 1 year after placement.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20542397     DOI: 10.1016/j.jemermed.2010.04.026

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  3 in total

1.  Pneumopericardium after Permanent Pacemaker Implantation.

Authors:  David Hennessy; Nicholas McKeag; Michael Roberts; Daniel Flannery; Richard McConville
Journal:  Tex Heart Inst J       Date:  2016-06-01

2.  An extremely rare combination: pneumopericardium, pneumoperitoneum, and subcutanous emphysema-a case report.

Authors:  Melek Zekiye Uluçam
Journal:  Cardiol Ther       Date:  2012-12-01

3.  Tension Pneumopericardium after Pericardiocentesis.

Authors:  Jinhyuck Lee; Bo Seung Kang; Changsun Kim; Hyuk Joong Choi
Journal:  J Korean Med Sci       Date:  2016-02-16       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.